Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa crossover study of DM-83 in type 2 diabetes mellitus
2007-004837-41Phase 2Completed
- Sponsor
- DiaMedica Therapeutics
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of DM-83 in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by DiaMedica Therapeutics. Primary endpoints: Change in mean post-prandial glucose and Change in mean post-prandial insulin. Started Oct 2007; status: completed.
02
Drugs
DM-83
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-004837-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004837-41.